Riziero Esposito Abate

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Federica Liotti

University of Naples Federico II

ITALY

View details

Paul Hofman

Université Côte d'Azur

FRANCE

View details

Marius Ilié

Professor, PU-PH

Centre Hospitalier Universitaire de Nice

FRANCE

View details

Luigi Alfano

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Luciano Giaco'

Head of Bioinformatics

Policlinico Universitario Agostino Gemelli

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Riziero Esposito Abate

Research Interests

Explore related searches

Contact this professor

Articles (13)

NONO Protein Regulates the Immune Response in Human Triple-Negative Breast Cancer Cells

The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer Cells

Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative

European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors

Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme

Bioinformatics: From NGS Data to Biological Complexity in Variant Detection and Oncological Clinical Practice

Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

A multiple network-based bioinformatics pipeline for the study of molecular mechanisms in oncological diseases for personalized medicine.

Challenges in bioinformatics approaches to tumor mutation burden analysis.

Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls

FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention.

Collaborators (5)

Federica Liotti

Paul Hofman

Marius Ilié

Luigi Alfano

Luciano Giaco'

Make your next move.